公司資料
ProPhase Labs 股價、新聞與催化劑
- 股票代碼:
- PRPH
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
0.01 USD (-0.66%)
收盤價
最後更新: 2026年10月1日
—
市值
股價為何變動
截至 2026年10月1日，PRPH 下跌 0.66%，收於 $0.0120。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
業務概覽
ProPhase Labs is a diagnostics and consumer-health company with exposure to testing, wellness, and specialty products. Its business is more diversified and opportunistic than a conventional biotech model.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, ProPhase sits in consumer health and diagnostics.
商業模式特徵
The company depends on product and test adoption, commercial execution, and the ability to monetize a small portfolio of assets.
生技產業定位
ProPhase is outside biotech proper and belongs to the consumer-diagnostics and health-products layer.
未來催化劑
- ProPhase Labs’ catalysts are diagnostics and consumer-health execution, plus any strategic update that clarifies the company’s next direction. Investors will care about whether the business can find a stable growth path.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。